Delivery Order SPE2DB20D9153-SPE2DB25FF21W
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/1.2 ml powder vials. The contract is firm fixed-price with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $46,422 to DMS Pharmaceutical Group Inc. on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare facilities. The delivery order utilizes firm fixed-price pricing with an...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,557.52, is for the supply of Xolair 150 mg/ml syringes. This award is under a larger DLA medical supply chain indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, valued at $1,547.40 with an ultimate completion date of September 10, 2025, was issued without set-aside designation. DMS Pharmaceutical Group competes effectively in federal procurement leveraging its small business status and established...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $38,685.00, is for the supply of the pharmaceutical product Xolair 150 mg/ml syringe. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,737 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 75 mg/0.5 ml syringe 0.5 ml, with an ultimate completion date of October 30, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,189.60 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Xolair 150 mg/ml syringes. This delivery order was issued under the DLA's Medical Supply Chain SPE2DB Indefinite Delivery Contract, a $499,999,999 single-award vehicle that enables the DLA to procure a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military...
- SPE2DB20D9153Indefinite Delivery Contract
- SPE2DB20D9153-SPE2DB25FF21WDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for $6,189.60 to supply Xolair 150 mg/ml syringes. The delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries firm fixed pricing and does not include a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facility needs globally. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide. The company's portfolio encompasses branded and generic drugs, over-the-counter medications, vaccines, and specialty pharmaceutical products across multiple categories. This delivery order for Xolair, a biologic immunosuppressant medication, exemplifies the company's role in providing essential pharmaceutical supplies to support military medical operations and patient care at federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/8/25 |